Neuroplasticity: from Bench to Practice
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Targeting Neuroplasticity for Balance Or Gait Deficit
August 2021 Volume 1 Issue 8 CADTH Horizon Scan The Portable Neuromodulation Stimulator: Targeting Neuroplasticity for Balance or Gait Deficit Health Technology Update Authors: Sara D. Khangura ISSN: 2563-6596 Disclaimer: The information in this document is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. While patients and others may access this document, the document is made available for informational purposes only and no representations or warranties are made with respect to its fitness for any particular purpose. The information in this document should not be used as a substitute for professional medical advice or as a substitute for the application of clinical judgment in respect of the care of a particular patient or other professional judgment in any decision-making process. The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse any information, drugs, therapies, treatments, products, processes, or services. While care has been taken to ensure that the information prepared by CADTH in this document is accurate, complete, and up to date as at the applicable date the material was first published by CADTH, CADTH does not make any guarantees to that effect. CADTH does not guarantee and is not responsible for the quality, currency, propriety, accuracy, or reasonableness of any statements, information, or conclusions contained in any third-party materials used in preparing this document. The views and opinions of third parties published in this document do not necessarily state or reflect those of CADTH. -
The Creation of Neuroscience
The Creation of Neuroscience The Society for Neuroscience and the Quest for Disciplinary Unity 1969-1995 Introduction rom the molecular biology of a single neuron to the breathtakingly complex circuitry of the entire human nervous system, our understanding of the brain and how it works has undergone radical F changes over the past century. These advances have brought us tantalizingly closer to genu- inely mechanistic and scientifically rigorous explanations of how the brain’s roughly 100 billion neurons, interacting through trillions of synaptic connections, function both as single units and as larger ensem- bles. The professional field of neuroscience, in keeping pace with these important scientific develop- ments, has dramatically reshaped the organization of biological sciences across the globe over the last 50 years. Much like physics during its dominant era in the 1950s and 1960s, neuroscience has become the leading scientific discipline with regard to funding, numbers of scientists, and numbers of trainees. Furthermore, neuroscience as fact, explanation, and myth has just as dramatically redrawn our cultural landscape and redefined how Western popular culture understands who we are as individuals. In the 1950s, especially in the United States, Freud and his successors stood at the center of all cultural expla- nations for psychological suffering. In the new millennium, we perceive such suffering as erupting no longer from a repressed unconscious but, instead, from a pathophysiology rooted in and caused by brain abnormalities and dysfunctions. Indeed, the normal as well as the pathological have become thoroughly neurobiological in the last several decades. In the process, entirely new vistas have opened up in fields ranging from neuroeconomics and neurophilosophy to consumer products, as exemplified by an entire line of soft drinks advertised as offering “neuro” benefits. -
Neurological Principles and Rehabilitation of Action Disorders: Rehabilitation Interventions
Neurorehabilitation and Neural Repair Neurological Principles and Supplement to 25(5) 33$--435 ©TheAuthor(s) 2011 Reprints and permission: http://W'NW. Rehabilitation of Action Disorders: sagepub.com/journalsPermissions.nav DOl: 10.1 1771154596831 1410942 Rehabilitation Interventions http://nnr.sagepub.com ®SAGE I 3 Valerie Pomeroy, PhD , Salvatore M. Aglioti, MD\ VictorW. Mark, MD , 4 6 Dennis McFarland, PhD , Cathy Stinear, PhD\ Steven L. Wolf, PhD , 7 7 Maurizio Corbetta, MD , and Susan M. Fitzpatrick, PhD ,8 This third chapter discusses the evidence for the rehabilitation of the most common movement disorders of the upper extremity. The authors also present a framework, building on the computation, anatomy, and physiology (CAP) model, for incorporating some of the principles discussed in the 2 previous chapters by Frey et al and Sathian et al in the practice of rehabilitation and for discussing potentially helpful interventions based on emergent neuroscience principles. Introduction General Principles for Delivery of Therapy Interventions Much of the evidence-based body of knowledge informing upper-limb rehabilitation has been generated from research Delivery of therapy interventions is multifaceted, and certain with patients recovering from stroke. It is not srnprising, general principles should be considered in each patient: given the number of affected individuals worldwide, that stroke would serve as the dominant model. However, many 1, The establishment of a 'contract' between people principles informing neurorehabilitation interventions can with neurological deficits and their therapy team. be translated from stroke into interventions for other neuro 2. Analysis of behavioral deficits in relation to known logical conditions when appropriate. principles of brain organization. -
Occupational Therapy Consensus Recommendations for Functional Neurological Disorder
Occasional essay J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2019-322281 on 30 July 2020. Downloaded from Occupational therapy consensus recommendations for functional neurological disorder Clare Nicholson ,1 Mark J Edwards,2 Alan J Carson,3 Paula Gardiner,4 Dawn Golder,5 Kate Hayward,1 Susan Humblestone,6 Helen Jinadu,7 Carrie Lumsden,8 Julie MacLean,9 Lynne Main,10 Lindsey Macgregor,11 Glenn Nielsen,2 Louise Oakley,12 Jason Price,13 Jessica Ranford,9 Jasbir Ranu,1 Ed Sum,14 Jon Stone 3 ► Additional material is ABSTRact jerks and dystonia), sensory symptoms, cognitive published online only. To view Background People with functional neurological deficits and seizure-like events (commonly known please visit the journal online as dissociative seizures or non- epileptic seizures). (http:// dx. doi. org/ 10. 1136/ disorder (FND) are commonly seen by occupational jnnp- 2019- 322281). therapists; however, there are limited descriptions in the Fatigue and persistent pain are also commonly literature about the type of interventions that are likely experienced as part of the disorder. Symptoms For numbered affiliations see to be helpful. This document aims to address this issue by can present acutely and resolve quickly or can be end of article. providing consensus recommendations for occupational long lasting. Regardless of duration, those affected therapy assessment and intervention. frequently experience high levels of distress, Correspondence to Methods The recommendations were developed in four disability, unemployment, social care utilisation and Mrs Clare Nicholson, Therapy 2 Services, University College stages. Stage 1: an invitation was sent to occupational reduced quality of life. The stigma associated with London Hospitals NHS therapists with expertise in FND in different countries to FND contributes to the burden of the diagnosis.3 Foundation Trust National complete two surveys exploring their opinions regarding OT is generally recognised as an integral part Hospital for Neurology and best practice for assessment and interventions for FND. -
Brain Stimulation and Neuroplasticity
brain sciences Editorial Brain Stimulation and Neuroplasticity Ulrich Palm 1,2,* , Moussa A. Chalah 3,4 and Samar S. Ayache 3,4 1 Department of Psychiatry and Psychotherapy, Klinikum der Universität München, 80336 Munich, Germany 2 Medical Park Chiemseeblick, Rasthausstr. 25, 83233 Bernau-Felden, Germany 3 EA4391 Excitabilité Nerveuse & Thérapeutique, Université Paris Est Créteil, 94010 Créteil, France; [email protected] (M.A.C.); [email protected] (S.S.A.) 4 Service de Physiologie—Explorations Fonctionnelles, Hôpital Henri Mondor, Assistance Publique—Hôpitaux de Paris, 94010 Créteil, France * Correspondence: [email protected] Electrical or magnetic stimulation methods for brain or nerve modulation have been widely known for centuries, beginning with the Atlantic torpedo fish for the treatment of headaches in ancient Greece, followed by Luigi Galvani’s experiments with frog legs in baroque Italy, and leading to the interventional use of brain stimulation methods across Europe in the 19th century. However, actual research focusing on the development of tran- scranial magnetic stimulation (TMS) is beginning in the 1980s and transcranial electrical brain stimulation methods, such as transcranial direct current stimulation (tDCS), tran- scranial alternating current stimulation (tACS), and transcranial random noise stimulation (tRNS), are investigated from around the year 2000. Today, electrical, or magnetic stimulation methods are used for either the diagnosis or exploration of neurophysiology and neuroplasticity functions, or as a therapeutic interven- tion in neurologic or psychiatric disorders (i.e., structural damage or functional impairment of central or peripheral nerve function). This Special Issue ‘Brain Stimulation and Neuroplasticity’ gathers ten research articles Citation: Palm, U.; Chalah, M.A.; and two review articles on various magnetic and electrical brain stimulation methods in Ayache, S.S. -
How Drugs Affect the Brain and Medication‐Assisted Treatment
How Drugs Affect the Brain And Medication‐Assisted Treatment Presented by Carl M. Dawson, M.S., MAC, LPC, Q‐SAP Learning Objectives After completing this section, participants will be able to: • Understand the scientific modalities neuroscientists use when studying addictions (Bio‐Psycho‐Social model of addictions, genetics and neuroplasticity) • Explore basic facts regarding the development and function of the human brain • Identify three “Feel Good” chemicals released by the brain (dopamine, serotonin, norepinephrine) • Discuss how addictive behaviors and drugs routinely “hijack” the human brain How Neuroscientists Study Addiction • All addictions (alcohol, drugs, gambling, porn, video games, food) activate the same neurological pleasure (reward) routes (pathways) in the brain • Addictionology uses the “Bio‐Psycho‐Social” model when studying addictions • Research has identified a strong genetic basis for all addiction behaviors (There is no single “addiction” gene, there are approx. 90 genes associated with addictions) How Neuroscientists Study Addiction • Remember: “Our genetics load the gun, but the environment pulls the trigger” • Addictions aren't only hijacking the brain’s activities but they have the ability to modify the neurological structures and activities of the brain (neuroplasticity) Neuroplasticity: is a term used in the field of neuroscience that defines the brain's ability to adapt, adjust and change based upon the strength and reward of the experience ‐ “Neurons that Fire Together, Wire Together” Donald O. Hebb (1904‐1985) Basic Facts and Regions of the Human Brain The average human brain weighs approximately three (3 lbs.) pounds, consisting of 60% protein (fat), possessing approximately 85 to 110 billion neurons and produces 15 watts of electricity, traveling at a speed of one‐half to 250 miles per hour Approximate Ages of the Human Brain 7,000 7,000 480,000 6 to 10 mil. -
New Trends in Connectomics
FOCUS FEATURE: New Trends in Connectomics Editorial: New Trends in Connectomics 1 2,3,4,5 Olaf Sporns and Danielle S. Bassett 1Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA 2Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA 3Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA, USA 4Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA 5Department of Electrical and Systems Engineering, University of Pennsylvania, Philadelphia, PA, USA ABSTRACT Connectomics is an integral part of network neuroscience. The field has undergone rapid Downloaded from http://direct.mit.edu/netn/article-pdf/02/02/125/1092204/netn_e_00052.pdf by guest on 28 September 2021 expansion over recent years and increasingly involves a blend of experimental and computational approaches to brain connectivity. This Focus Feature on “New Trends in an open access journal Connectomics” aims to track the progress of the field and its many applications across different neurobiological systems and species. The idea that connections among neural elements are crucial for brain function has been central to modern neuroscience almost since its inception. Building on this idea, the emerg- ing field of connectomics adds several new and important components. First, connectomics provides comprehensive maps of neural connections, with the ultimate goal of achieving com- plete coverage of any given nervous system. Second, connectomics delivers insights into the principles that underlie network architecture and uncovers how these principles support net- work function. These dual aims can be accomplished through the confluence of new experi- mental techniques for mapping connections and new network science methods for modeling and analyzing the resulting large connectivity datasets. -
The Brain That Changes Itself
The Brain That Changes Itself Stories of Personal Triumph from the Frontiers of Brain Science NORMAN DOIDGE, M.D. For Eugene L. Goldberg, M.D., because you said you might like to read it Contents 1 A Woman Perpetually Falling . Rescued by the Man Who Discovered the Plasticity of Our Senses 2 Building Herself a Better Brain A Woman Labeled "Retarded" Discovers How to Heal Herself 3 Redesigning the Brain A Scientist Changes Brains to Sharpen Perception and Memory, Increase Speed of Thought, and Heal Learning Problems 4 Acquiring Tastes and Loves What Neuroplasticity Teaches Us About Sexual Attraction and Love 5 Midnight Resurrections Stroke Victims Learn to Move and Speak Again 6 Brain Lock Unlocked Using Plasticity to Stop Worries, OPsessions, Compulsions, and Bad Habits 7 Pain The Dark Side of Plasticity 8 Imagination How Thinking Makes It So 9 Turning Our Ghosts into Ancestors Psychoanalysis as a Neuroplastic Therapy 10 Rejuvenation The Discovery of the Neuronal Stem Cell and Lessons for Preserving Our Brains 11 More than the Sum of Her Parts A Woman Shows Us How Radically Plastic the Brain Can Be Appendix 1 The Culturally Modified Brain Appendix 2 Plasticity and the Idea of Progress Note to the Reader All the names of people who have undergone neuroplastic transformations are real, except in the few places indicated, and in the cases of children and their families. The Notes and References section at the end of the book includes comments on both the chapters and the appendices. Preface This book is about the revolutionary discovery that the human brain can change itself, as told through the stories of the scientists, doctors, and patients who have together brought about these astonishing transformations. -
Michael M. Merzenich
Michael M. Merzenich BORN: Lebanon, Oregon May 15, 1942 EDUCATION: Public Schools, Lebanon, Oregon (1924–1935) University of Portland (Oregon), B.S. (1965) Johns Hopkins University, Ph.D. (1968) University of Wisconsin Postdoctoral Fellow (1968–1971) APPOINTMENTS: Assistant and Associate Professor, University of California at San Francisco (1971–1980) Francis A. Sooy Professor, University of California at San Francisco (1981–2008) President and CEO, Scientifi c Learning Corporation (1995–1996) Chief Scientifi c Offi cer, Scientifi c Learning Corporation (1996–2003) Chief Scientifi c Offi cer, Posit Science Corporation (2004–present) President and CEO, Brain Plasticity Institute (2008–present) HONORS AND AWARDS (SELECTED): Cortical Discoverer Prize, Cajal Club (1994) IPSEN Prize (Paris, 1997) Zotterman Prize (Stockholm, 1998) Craik Prize (Cambridge, 1998) National Academy of Sciences, U.S.A. (1999) Lashley Award, American Philosophical Society (1999) Thomas Edison Prize (Menlo Park, NJ, 2000) American Psychological Society Distinguished Scientifi c Contribution Award (2001) Zülch Prize, Max-Planck Society (2002) Genius Award, Cure Autism Now (2002) Purkinje Medal, Czech Academy (2003) Neurotechnologist of the Year (2006) Institute of Medicine (2008) Michael M. Merzenich has conducted studies defi ning the functional organization of the auditory and somatosensory nervous systems. Initial models of a commercially successful cochlear implant (now distributed by Boston Scientifi c) were developed in his laboratory. Seminal research on cortical plasticity conducted in his laboratory contributed to our current understanding of the phenomenology of brain plasticity across the human lifetime. Merzenich extended this research into the commercial world by co-founding three brain plasticity-based therapeutic software companies (Scientifi c Learning, Posit Science, and Brain Plasticity Institute). -
Protocol Title: Cracking Addiction
Protocol Title: Cracking addiction: does BRAIN Stimulation-induced neuroplasticity reverse prefrontal cortex hypoactivity in cocaine and neW stImulanTs addiCtion in Humans (BRAIN SWITCH)? Abbreviated title: Transcranial Magnetic Stimulation for Cocaine Addiction Protocol Number: 1496 Date of Approval: June 29, 2017 Principal Investigator Name, Degree Branch/Institute Phone E-mail Massimo di Dept. of +39 0871358928 [email protected] Giannantonio, Neuroscience, MD Imaging and Clinical Sciences (ITAB) – University of Chieti Co- Principal Investigator Name, Degree Branch/Institute Phone E-mail Giovanni Dept. of +39 08713556914 [email protected] Martinotti, M.D., Neuroscience, Ph.D. Imaging and Clinical Sciences (ITAB) – University of Chieti Villa Maria Pia Clinic - Rome Associate Investigators Name, Degree Branch/Institute Phone E-mail Chiara MNB/NINDS +39 3281264713 [email protected] Montemitro, M.D. Mauro MNB/NINDS +39 3391979487 [email protected] Pettorruso, M.D. Lamberto Office of +39 3474727282 [email protected] Manzoli, Ph.D. Biostatistics/ University of Ferrara Referral Contact Name, Degree Branch/Institute Phone E-mail Mauro Pettorruso, MNB/NINDS +39 3391979487 [email protected] M.D. 1 Accountable Investigator Name, Degree Branch/Institute Phone E-mail Giovanni Dept. of +39 08713556914 [email protected] Martinotti, M.D., Neuroscience, Ph.D. Imaging and Clinical Sciences (ITAB) – University of Chieti Villa Maria Pia Clinic - Rome 2 A. Précis Background: Cocaine use disorder (CUD) are a major public health concern, associated with high relapse rates, significant disability and substantial mortality. In Italy, it has been recently estimated that up to 4.8% of subjects between the ages of 15-64 have assumed cocaine at least once, whereas 1.3% subjects currently have a diagnosis of CUD. -
Connectomics of Morphogenetically Engineered Neurons As a Predictor of Functional Integration in the Ischemic Brain
http://www.diva-portal.org This is the published version of a paper published in Frontiers in Neurology. Citation for the original published paper (version of record): Sandvig, A., Sandvig, I. (2019) Connectomics of Morphogenetically Engineered Neurons as a Predictor of Functional Integration in the Ischemic Brain Frontiers in Neurology, 10: 630 https://doi.org/10.3389/fneur.2019.00630 Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161446 REVIEW published: 12 June 2019 doi: 10.3389/fneur.2019.00630 Connectomics of Morphogenetically Engineered Neurons as a Predictor of Functional Integration in the Ischemic Brain Axel Sandvig 1,2,3 and Ioanna Sandvig 1* 1 Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway, 2 Department of Neurology, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway, 3 Department of Pharmacology and Clinical Neurosciences, Division of Neuro, Head, and Neck, Umeå University Hospital, Umeå, Sweden Recent advances in cell reprogramming technologies enable the in vitro generation of theoretically unlimited numbers of cells, including cells of neural lineage and specific neuronal subtypes from human, including patient-specific, somatic cells. Similarly, as demonstrated in recent animal studies, by applying morphogenetic neuroengineering principles in situ, it is possible to reprogram resident brain cells to the desired phenotype. These developments open new exciting possibilities for cell replacement therapy in Edited by: stroke, albeit not without caveats. -
Patient-Tailored Connectomics Visualization for the Assessment of White Matter Atrophy in Traumatic Brain Injury
Patient-Tailored Connectomics Visualization for the Assessment of White Matter Atrophy in Traumatic Brain Injury The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Irimia, Andrei, Micah C. Chambers, Carinna M. Torgerson, Maria Filippou, David A. Hovda, Jeffry R. Alger, Guido Gerig, et al. 2012. Patient-tailored connectomics visualization for the assessment of white matter atrophy in traumatic brain injury. Frontiers in Neurology 3:10. Published Version doi://10.3389/fneur.2012.00010 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:8462352 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA METHODS ARTICLE published: 06 February 2012 doi: 10.3389/fneur.2012.00010 Patient-tailored connectomics visualization for the assessment of white matter atrophy in traumatic brain injury Andrei Irimia1, Micah C. Chambers 1, Carinna M.Torgerson1, Maria Filippou 2, David A. Hovda2, Jeffry R. Alger 3, Guido Gerig 4, Arthur W.Toga1, Paul M. Vespa2, Ron Kikinis 5 and John D. Van Horn1* 1 Laboratory of Neuro Imaging, Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA 2 Brain Injury Research Center, Departments of Neurology and Neurosurgery, University of California Los Angeles, Los Angeles, CA, USA 3 Department of Radiology, David